y 26763 has been researched along with phosphorylcholine in 1 studies
| Studies (y 26763) | Trials (y 26763) | Recent Studies (post-2010) (y 26763) | Studies (phosphorylcholine) | Trials (phosphorylcholine) | Recent Studies (post-2010) (phosphorylcholine) |
|---|---|---|---|---|---|
| 33 | 0 | 4 | 5,308 | 255 | 1,893 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujisawa, H; Kobayashi, S; Kudo, A; Kunitsugu, I; Kurokawa, T; Ogasawara, K; Ogawa, A; Shirao, S; Soma, M; Suzuki, M; Yoneda, H | 1 |
1 other study(ies) available for y 26763 and phosphorylcholine
| Article | Year |
|---|---|
Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway.
Topics: Animals; Basilar Artery; Benzopyrans; Cerebral Angiography; Cisterna Magna; Disease Models, Animal; Dogs; Eicosapentaenoic Acid; Female; Injections; Male; Phosphorylcholine; Protein Kinase Inhibitors; rho-Associated Kinases; Signal Transduction; Sphingosine; Subarachnoid Hemorrhage; Time Factors; Vasoconstriction; Vasodilator Agents; Vasospasm, Intracranial | 2008 |